Diabetic Medical Equipment Supplier

Product Description

1.Background of product development

In 1998, three American scientists, who are Robert F.Furchgott, Louis J.Ignarro, and Ferid Murad found that the NO in human body is the best mediator for blood vessel dilation, and this discovery wonthe Nobel Prize in Physiology or Medicine. Near-Infrared Therapy systems are developed on basis of this discovery.

NO is an important signalling molecule in the vascular system.

NO is also important for signalling in nerve system.

NO is involved in the normal defence against bacterial and parasitic infections.

NO can promote bone formation and wound healing.

2.Treatment principle

Monochromatic infrared ray with wavelength of 850nm-950nm can penetrate 5cm to hypoderm, be absorbed by the endothelial cells that line the inner surface and make NO release locally, the NO in human body is the best mediator for blood vessel dilation.

The infrared rays absorbed by body cells could promote angiectasis and improve local blood circulation.

Improvement of blood circulatin can accelerate wound healing, relieve pain, accelerating the concrescence of the wounds and promoting bone formation and other effect on peripheral neuropathy.

3.Clinical Application

4.Easy Operation

Stabukuzed monochromatic infrared ray between 850-950nm

Adjustment of time:10min,20min,30min,40min.

Adjustment of energy: Mid, Moderate, Strong

Mild:2.5mw(single light-emitting diode)

Moderate:3.0mw (single light-emitting diode)

Strong:3.5mw (single light-emitting diode)

5.Clinical trials in 3 hospital